Fig. 7From: Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75Drug sensitivity analysis in GIRS subgroups (A) Nine drugs that were more sensitive to high GIRS patients. B Six drugs that were more sensitive to low GIRS patientsBack to article page